Acne – Epidemiology – Epidemiology – Acne – Asia Pacific
Clarivate Epidemiology's coverage of acne comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of acne for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan, and 10 years for the other countries covered in this report.
Clarivate Epidemiology's acne forecast will answer the following questions:
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of acne over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In total, Clarivate Epidemiology forecasts nine acne patient populations, as follows:
Acne - Epidemiology - Epidemiology - Acne - Asia Pacific
Introduction
Key Findings
Key Updates
Total Prevalence of Acne Vulgaris per 100 Among People of All Ages in 2021 and 2031
Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Acne Vulgaris over the Next 10 Yearsttttttttt
Epidemiology
Methods
Total Prevalent Cases of Acne Vulgaris
Physiological Acne
Clinical Acne
Clinical Acne by Subtype
Total Prevalent Cases by Type of Pigmentation
Total Prevalent Cases by Type of Scar
Reference Materials
Literature Review
Studies Included in the Analysis of Acne Vulgaris
Studies Excluded from the Analysis of Acne Vulgaris
Risk/Protective Factors
Risk/Protective Factors for Acne Vulgaris
Bibliography
Abbreviations
Glossary
Surup Dey
Surup Dey, M.L.T., M.P.H., is an epidemiologist at Clarivate. Previously, he worked in the field of medical diagnostic microbiology and was involved in the diagnosis of rare hematological disorders. Mr. Dey has a background in medical laboratory science from Christian Medical College in Vellore and a postgraduate degree in public health specializing in epidemiology from Manipal University.
